Human Crossveinless-2/CV-2 Antibody, R&D Systems™

Crossveinless-2/CV-2/BMPER

LYOPH

Western Blot

Unconjugated

Rat

Human

Q8N8U9

168667

Mouse myeloma cell line NS0-derived recombinant human Crossveinless-2/CV-2 Val34-Arg685 Accession # Q8N8U9

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human Crossveinless-2/CV-2 in direct ELISAs and Western blots. In Western blots, 25% cross-reactivity with recombinant mouse CV-2 is observed.

355304

Western Blot 1 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

BMP binding endothelial regulator, BMP-binding endothelial regulator precursor protein, BMP-binding endothelial regulator protein, BMPER, Bone morphogenetic protein-binding endothelial cell precursor-derived regulator, CRIM3, crossveinless 2, crossveinless-2, Cv2, CV-2, hCV2, KIAA1965, Protein crossveinless-2

BMPER

IgG2a

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.